Public preview. Funding rounds, founders, and growth signals require a free account.
Unlock full profile
Invirsa, Inc.
Clinical-stage pharma developing INV-102 eyedrop for ocular conditions like dry eye and DNA damage.
Series APharmaColumbus, OH1-10 employees
Total raised
$12.7M
Last round
Equity
$2.9M · Jul 2025
Stage
Series A
Status
Active
Founders & team
Growth signals
Track Invirsa, Inc. on FlareSight
Get notified the moment Invirsa, Inc. files a new round, hires execs, or shows traction signals.
Create free accountAbout this data
FlareSight surfaces funding data from SEC Form D filings within hours of submission. Browse our full startup funding database to find more recently funded companies.